Inovio Pharmaceuticals (INO) Held by Superinvestors
INOVIO PHARMACEUTICALS INC (INO) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $1.85M based on the latest available SEC Form 13F filings for the quarter ended September 30, 2026.
Renaissance Technologies LLC is currently the largest disclosed institutional shareholder of INO tracked by InsiderSet, reporting ownership valued at approximately $1.85M in its September 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.16M, representing an estimated gain of +17.21% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed INO value among the investors covered in this analysis. Major shareholders include Renaissance Technologies LLC, and several other long-term asset managers with concentrated positions in INOVIO PHARMACEUTICALS INC (INO).
This page ranks the largest institutional INO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Jim Simons | 0.00% | 1,513,187 | $1,846,088 | $2,163,857 | +$317,769 | +17.21% |
Frequently asked questions about INO
Who are the largest superinvestors holding INO?
The largest superinvestors holding INO in the latest SEC Form 13F filings include Renaissance Technologies LLC. InsiderSet ranks these superinvestors by their latest reported INO position.
What does the INO superinvestors page include?
This page tracks INO positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. INOVIO PHARMACEUTICALS INC (INO) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold INO?
InsiderSet currently tracks 1 superinvestors reporting INO holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own INO.
How much INO stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $1.85M in INO holdings for Q3 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were INO superinvestor holdings last updated?
The latest INO superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended September 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor INO holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its INO position after the reporting date.
Are superinvestors buying or selling INO?
Buying and selling can be analyzed by comparing INO positions across consecutive 13F reporting periods. InsiderSet's INO Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View INO ownership changes.
How have superinvestor INO holdings changed over time?
InsiderSet tracks INO holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.